Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

Slični predmeti

• Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
  od: Hill, Andrew, i dr.
  Izdano: (2016)
• Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
  od: Andrew Hill, i dr.
  Izdano: (2016)
• Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
  od: Hill, Andrew, i dr.
  Izdano: (2017)
• Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
  od: Hill, Andrew, i dr.
  Izdano: (2015)
• Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
  od: Melissa Barber, i dr.
  Izdano: (2020)